Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP483847.RAzJUuexoY0IekUE55ex_Lxp_ie8Z3bWlBxRo4vPAkFzI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP483847.RAzJUuexoY0IekUE55ex_Lxp_ie8Z3bWlBxRo4vPAkFzI130_assertion type Assertion NP483847.RAzJUuexoY0IekUE55ex_Lxp_ie8Z3bWlBxRo4vPAkFzI130_head.
- NP483847.RAzJUuexoY0IekUE55ex_Lxp_ie8Z3bWlBxRo4vPAkFzI130_assertion description "[Here, we investigated the oncolytic potential of two commercially available live attenuated vaccines, Moraten measles and Jeryl-Lynn mumps, in a murine model of intraperitoneal human ovarian cancer and compared their efficacies against a recombinant oncolytic measles virus (MV-CEA) that is being tested in a phase I clinical trial.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP483847.RAzJUuexoY0IekUE55ex_Lxp_ie8Z3bWlBxRo4vPAkFzI130_provenance.
- NP483847.RAzJUuexoY0IekUE55ex_Lxp_ie8Z3bWlBxRo4vPAkFzI130_assertion evidence source_evidence_literature NP483847.RAzJUuexoY0IekUE55ex_Lxp_ie8Z3bWlBxRo4vPAkFzI130_provenance.
- NP483847.RAzJUuexoY0IekUE55ex_Lxp_ie8Z3bWlBxRo4vPAkFzI130_assertion SIO_000772 15746945 NP483847.RAzJUuexoY0IekUE55ex_Lxp_ie8Z3bWlBxRo4vPAkFzI130_provenance.
- NP483847.RAzJUuexoY0IekUE55ex_Lxp_ie8Z3bWlBxRo4vPAkFzI130_assertion wasDerivedFrom befree-2016 NP483847.RAzJUuexoY0IekUE55ex_Lxp_ie8Z3bWlBxRo4vPAkFzI130_provenance.
- NP483847.RAzJUuexoY0IekUE55ex_Lxp_ie8Z3bWlBxRo4vPAkFzI130_assertion wasGeneratedBy ECO_0000203 NP483847.RAzJUuexoY0IekUE55ex_Lxp_ie8Z3bWlBxRo4vPAkFzI130_provenance.